[
    [
        {
            "time": "",
            "original_text": "九洲药业（603456）：CMDO API+双线发展 业绩符合预期",
            "features": {
                "keywords": [
                    "九洲药业",
                    "CMDO",
                    "API",
                    "双线发展",
                    "业绩"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "制药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "九洲药业（603456）：CMDO API+双线发展 业绩符合预期",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "泰格一天豪掷9亿投向新医药 康龙化成、凯莱英一众CXO扎堆进入",
            "features": {
                "keywords": [
                    "泰格",
                    "康龙化成",
                    "凯莱英",
                    "CXO",
                    "投资"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "制药",
                    "医疗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "泰格一天豪掷9亿投向新医药 康龙化成、凯莱英一众CXO扎堆进入",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "食品饮料行业9月社零数据点评：社零连续2个月实现正增长 烟酒增速大幅提升",
            "features": {
                "keywords": [
                    "食品饮料",
                    "社零",
                    "烟酒",
                    "正增长",
                    "增速提升"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "消费品",
                    "零售"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "食品饮料行业9月社零数据点评：社零连续2个月实现正增长 烟酒增速大幅提升",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "凯莱英定增募资23亿元到账 高瓴资本以每股227元高价参与显“真爱”",
            "features": {
                "keywords": [
                    "凯莱英",
                    "定增",
                    "高瓴资本",
                    "募资",
                    "高价参与"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "制药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "凯莱英定增募资23亿元到账 高瓴资本以每股227元高价参与显“真爱”",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "十倍股之大博医疗：超高毛利率堪比骨科器械茅台",
            "features": {
                "keywords": [
                    "大博医疗",
                    "毛利率",
                    "骨科器械",
                    "茅台"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗器械"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "十倍股之大博医疗：超高毛利率堪比骨科器械茅台",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        }
    ]
]